T39.4X3
Poisoning by antirheumatics, not elsewhere classified, assault
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T39.4X3 refers to poisoning caused by antirheumatics as a result of assault. This classification is used when someone intentionally ingests or is exposed to medications used to treat rheumatic conditions in an act of violence. Understanding the nature of this injury and its classification can provide insight into the medical and legal considerations involved.
Causes & Symptoms
Clinical Causes: Intentional harm through assault involving antirheumatic medications Use of antirheumatics as a weapon during an attack Malicious administration of these drugs to harm someone
Key Symptoms: Nausea and vomiting Abdominal pain Dizziness or lightheadedness Confusion or altered mental status Drowsiness or unconsciousness Gastrointestinal discomfort Fainting Signs of organ toxicity depending on the substance involved
Diagnostic & Treatment
Diagnosis Path: Blood tests to detect the presence and level of antirheumatic drugs Urinalysis to identify drug metabolites Assessment of symptoms and physical examination History-taking to understand circumstances of exposure, including potential assault
Treatment Protocols: Immediate supportive care to stabilize vital signs Gastrointestinal decontamination procedures such as activated charcoal administration, if appropriate Use of specific antidotes if available and indicated for the particular antirheumatic involved Monitoring organ function, especially liver and kidney Treating symptoms such as nausea or arrhythmias Psychosocial support or intervention if the poisoning is part of a broader assault incident
Clinical Advice & FAQs
Billing Guidance
Is T39.4X3 a billable ICD-10 code?
Yes, T39.4X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T39.4X3?
Clinical documentation must specify the nature of Poisoning by antirheumatics, not elsewhere classified, assault and any associated comorbidities for accurate reporting.
Cite this Clinical Reference